Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
Vincent Blay, Mu‐Chun Li, Sunita P. Ho, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 7, pp. 1309-1320
Open Access | Times Cited: 15

Showing 15 citing articles:

The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Dechao Feng, Weizhen Zhu, Jie Wang, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Bioinformatics and computational analyses of kidney stone modulatory proteins lead to solid experimental evidence and therapeutic potential
Sunisa Yoodee, Visith Thongboonkerd
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114217-114217
Open Access | Times Cited: 10
Oncological aspects of urolithiasis
Jozef Marenčák
Urologie pro praxi (2025) Vol. 26, Iss. 1, pp. 17-22
Closed Access
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database
Pingyun Ding, Qinghua Luo, Liping Cao
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin
Matthew Mahoney, Jonathan Helander, Anoopjit Singh Kooner, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 3
Bioisosteric replacements of tyrosine kinases inhibitors to make potent and safe chemotherapy against malignant cells
Navabshan Irfan, S. Balasubramaniyan, Davoodbasha Mubarak Ali, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9437-9447
Open Access | Times Cited: 9
Advances in structure-based drug design targeting membrane protein markers in prostate cancer
J.P. Batista-Silva, Diana Gomes, Sérgio F. Sousa, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104130-104130
Open Access | Times Cited: 1
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
M.C. Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients
Yuan Du, Vincent Blay, Jorge Mena, et al.
Journal of Pediatric Urology (2020) Vol. 17, Iss. 2, pp. 214.e1-214.e11
Open Access | Times Cited: 6
Understanding the link between kidney stones and cancers of the upper urinary tract and bladder.
Meredith Mihalopoulos, Alan Yaghoubian, Shirin Razdan, et al.
PubMed (2022) Vol. 10, Iss. 5, pp. 277-298
Closed Access | Times Cited: 4
Identification of dual inhibitors for EGFR(T790M/C797S) and VEGFR-2 in Non-Small Cell Lung Cancer from Moringa oleifera derived phytochemicals: An In-silico Approach
Md. Masudur Rahman Munna, Md. Touki Tahamid Tusar, Saima Sajnin Shanta, et al.
Research Square (Research Square) (2024)
Open Access
Intracellular autoactivation and surface location of hepsin, TMPRSS2, and TMPRSS13
Zhecheng Jin, Yue Zhang, Wenjun Chen, et al.
Life Sciences (2024) Vol. 361, pp. 123299-123299
Closed Access
Comparison of ATP-binding pockets and discovery of homologous recombination inhibitors
Vincent Blay, Saule Gailiunaite, Chih-Ying Lee, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 70, pp. 116923-116923
Open Access | Times Cited: 1
Pro-tumor and prothrombotic activities of hepsin in colorectal cancer cells and suppression by venetoclax
M.C. Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
POTENTIAL MARKERS OF RECURRENCY OF UROLITHIASIS DISEASE AND THE ROLE OF STONE FORMATION INHIBITORS IN RECURRENT CALCIUM OXALATE NEPHROLITHIASIS
А. А. Буданов, В. Л. Медведев, А. Н. Курзанов, et al.
Crimea Journal of Experimental and Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 85-92
Open Access
Page 1

Scroll to top